Under construction – not a live service
Sign in
Taking people in PolandNo phase

Measuring Inflammation Markers in Women With PCOS

Compares blood inflammation markers in women with PCOS and women without PCOS.

Plain-language title generated from the registry record
Registry title: Pro- and Anti-inflammatory Cytokines in PCOS

Key facts

Where
Krakow, PolandSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18-45 years, with or without polycystic ovary syndrome (PCOS), to measure inflammation markers in their blood.

Age
18 to 45 years
Sex
Women only

Main reasons for not taking part

  • Previous removal of at least one ovary
  • Treated diabetes of any type
  • Diagnosed and treated metabolic diseases
  • Diagnosed and treated autoimmune diseases
  • Diagnosed and treated autoinflammatory diseases

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Source: NCT06793085, who can take part

Where in Poland

  • Jagiellonian UniversityKrakow, PolandContact: Iwona Gawron, Ph.D., M.D.Taking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Jagiellonian University
Trial code
NCT06793085
Record updated
18 March 2026
Original description
The study will involve measurements and comparisons of the concentrations of pro-inflammatory cytokines: IL-6, TNF-α, IL-18, as well as anti-inflammatory cytokine IL-4 in women with polycystic ovary syndrome (PCOS) and insulin resistance, women with polycystic ovary syndrome without carbohydrate metabolism disorders, and women without PCOS (control group).Read full original descriptionShow less

Assessment of the Concentrations of Pro- and Anti-inflammatory Cytokines and Their Association With the Metabolic Profile of Women With PCOS

The study will involve measurements and comparisons of the concentrations of pro-inflammatory cytokines: IL-6, TNF-α, IL-18, as well as anti-inflammatory cytokine IL-4 in women with polycystic ovary syndrome (PCOS) and insulin resistance, women with polycystic ovary syndrome without carbohydrate metabolism disorders, and women without PCOS (control group).

Inclusion: women aged 18-45 years.

Exclusion: previous removal of at least one ovary; treated diabetes of any type; diagnosed and treated metabolic diseases; diagnosed and treated autoimmune diseases; diagnosed and treated autoinflammatory diseases.

ClinicalTrials.gov NCT06793085